Salarius Pharmaceuticals Share Price (NASDAQ: SLRX)
$5.7
▲
0.02
(0.35%)
Last updated on
Check the interactive Salarius Pharmaceuticals Stock chart to analyse performance
Salarius Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$5.60Today's High:$5.70
1.75%
Downside
Day's Volatility :1.75%
Upside
0.0%
- 52 Weeks Low:$4.7652 Weeks High:$108.00
16.49%
Downside
52 Weeks Volatility :95.59%
Upside
94.72%
Salarius Pharmaceuticals Stock Returns
Salarius Pharmaceuticals Inc. Key Stats
Check Salarius Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Salarius Pharmaceuticals Stock including INR - Dollar returns
The Salarius Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Salarius Pharmaceuticals investment value today
Current value as on today
₹30,617
Returns
Returns from Salarius Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Salarius Pharmaceuticals Stock
Global Institutional Holdings in Salarius Pharmaceuticals Inc.
Name
Holdings %
UBS Group AG
0.44%
Goldman Sachs Group Inc
0.22%
TWO SIGMA SECURITIES, LLC
0.20%
Geode Capital Management, LLC
0.15%
Citigroup Inc
0.08%
Tower Research Capital LLC
0.04%
Analyst Recommendation on Salarius Pharmaceuticals Stock
Sell
0%Buy
50%Hold
50%Sell
Based on 6 Wall street analysts offering stock ratings for Salarius Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Salarius Pharmaceuticals Share Price Target
What analysts predicted
Upside of 356.14%
Target:
$26.00
Current:
$5.70
Salarius Pharmaceuticals share price target is $26.00, a slight Upside of 356.14% compared to current price of $5.70 as per analysts' prediction.
Salarius Pharmaceuticals Stock Insights
Price Movement
In the last 1 month, SLRX stock has moved down by -51.5%SLRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 147.0%SLRX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 211.7%
Salarius Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Salarius Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.
Salarius Pharmaceuticals Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -39.68% | -63.46% | -74.67% | -99.12% | -99.79% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | 0.0 | -6.6 | -1.44 | NA | -0.39 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Sell | $3.0M | -99.79% | NA | 0.0% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Salarius Pharmaceuticals Inc.
Key Management of Salarius Pharmaceuticals Inc.
Important FAQs about investing in SLRX Stock from India :
What is Salarius Pharmaceuticals share price today?
Salarius Pharmaceuticals share price today is $5.70 as on at the close of the market. Salarius Pharmaceuticals share today touched a day high of $5.70 and a low of $5.60.
What is the 52 week high and 52 week low for Salarius Pharmaceuticals share?
Salarius Pharmaceuticals share touched a 52 week high of $108.00 and a 52 week low of $4.76. Salarius Pharmaceuticals stock price today i.e. is closed at $5.70, lower by 94.72% versus the 52 week high.
How to invest in Salarius Pharmaceuticals Stock (SLRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Salarius Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Salarius Pharmaceuticals Shares that will get you 0.2632 shares as per Salarius Pharmaceuticals share price of $5.70 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Salarius Pharmaceuticals Stock (SLRX) from India?
Indian investors can start investing in Salarius Pharmaceuticals (SLRX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Salarius Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Salarius Pharmaceuticals share’s latest price of $5.70 as on August 30, 2025 at 1:29 am IST, you will get 1.7544 shares of Salarius Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Salarius Pharmaceuticals has given to Indian investors in the last 5 years?
Salarius Pharmaceuticals stock has given -99.79% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%